Harvey Cantor, M.D., Dana-Farber Cancer Institute (image) Dana-Farber Cancer Institute Share Print E-Mail Caption Harvey Cantor, M.D., and his colleagues at Dana-Farber Cancer Institute have demonstrated a new strategy for treating autoimmune disease that successfully blocked the development of rheumatoid arthritis in a mouse model. They say it holds promise for improved treatment of arthritis and other autoimmune disorders in people. Credit Sam Ogden Usage Restrictions None Share Print E-Mail Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.